Anticancer strategies (transporter inhibitors to starve tumor cells of essential amino acids or cytotoxic molecules that could be selectively transported by SLC6A14) are also being actively explored for other tumor types which have been shown to overexpress SLC6A14 [18, 42]. Here, SLC6A14 is linked to neoplasm.